Tafenoquine: all 32 studies that test it
Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Tafenoquine Drug Levels in Small ChildrenNot yet recruitingNCT07835321Phase 2
- Pharmacokinetic (PK) Study of Tafenoquine in Healthy AdultsNot yet recruitingNCT07373743Early Phase 1
- Tafenoquine and ACTs (TADORE- Plus)Not yet recruitingNCT07060794Phase 4
- Postpartum 8-aminoquinoline Breast Milk StudyNot yet recruitingNCT07060404Phase 2/3
- Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean ChildrenRecruitingNCT07052162Phase 4
- An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and OlderRecruitingNCT06666491Phase 3
- B-FREE Chronic Babesiosis StudyRecruitingNCT06656351Phase 2
- Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for BabesiosisRecruitingNCT06207370Phase 2
- A Revised Tafenoquine Dose to Improve Radical Cure for Vivax MalariaRecruitingNCT06148792Phase 3
- A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease ProgressionNot yet recruitingNCT05947812Phase 2
- ACT vs CQ With Tafenoquine for P. Vivax Mono-infectionRecruitingNCT05788094Phase 4
- Southeast Asia Dose Optimization of TafenoquineRecruitingNCT04704999Phase 4
- Tafenoquine in Patients With Mild to Moderate COVID-19CompletedNCT04533347Phase 2Results posted
- Long-Term Safety Study of TafenoquineCompletedNCT03320174Phase 2Results posted
- Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) MalariaCompletedNCT02802501Phase 3Results posted
- A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) MalariaCompletedNCT02563496Phase 2Results posted
- An Evaluation of Weekly TafenoquineCompletedNCT02488980Phase 2Results posted
- Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax MalariaCompletedNCT02216123Phase 3Results posted
- Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax RelapseCompletedNCT01376167Phase 2Results posted
- Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in AdultsTerminatedNCT01290601Phase 2Results posted
- Vivax Elimination With Tafenoquine (VET) StudyCompletedNCT06575647Phase 4
- Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in MaliCompletedNCT05081089Phase 2
- Tafenoquine and Primaquine in Colostrum and Breast MilkWithdrawnNCT04984759Phase 4
- Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)CompletedNCT04609098Phase 2
- Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and PrimaquineCompletedNCT04411836Phase 3
- Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)CompletedNCT02658435Phase 1
- Evaluation of Weekly TafenoquineCompletedNCT02491606Phase 2
- A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium FalciparumCompletedNCT02488902Phase 2
- A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine TetraphosphateCompletedNCT02184637Phase 1
- Tafenoquine Thorough QTc Study in Healthy SubjectsCompletedNCT01928914Phase 1
- G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)CompletedNCT01205178Phase 1
- Tafenoquine/Chloroquine DDI StudyCompletedNCT00871156Phase 1